Sysgroup Share Discussion Threads

[interceptor2] 11/6/2009 08:39

See trading statement below......................

Pre-Close Trading Update for Year Ended 31 May 2009

System C (AIM:SYS), a leading provider of information solutions and services to the healthcare sector, is pleased to announce that it expects profit for the financial year ending 31 May 2009 to be at or around the top end of market expectations with pre tax profits over 20% higher than for the year to 31st May 2008.

Services

The services division has continued to perform well during the year, and has worked on National Program solutions for both the NHS Connecting for Health and for Local Service Providers across hundreds of NHS Trusts. We have also worked with Connecting for Health to create standard clinical workflows and clinical content that can be used in any NHS system deployment. Our healthcare improvement teams have won a number of significant business change contracts directly with NHS Trusts in the acute and primary care sectors, and this has furthered our strategy of diversifying our client base.

Products

The Company is achieving continued growth in sales from its products division, which is benefiting from ongoing investment in its innovative product set - Medway Sigma. We have had over a dozen successful deployments of Medway Sigma this year including patient management, maternity, and business intelligence systems, and the sales pipeline continues to grow.

Acquisitions

In May 2009, the Company completed its 3rd acquisition, the specialist services and healthcare technology company, Bluestar Systems. Work is already underway to incorporate the Bluestar product range, including Radio-frequency identification (RFID) technology, into Medway Sigma. The Company continues to review selective acquisition opportunities that offer true long term strategic value to the Company.

Outlook

Looking forward, System C has a substantial order book for products and services for 2009/10 and beyond, and the Board is confident of achieving continued growth.

[interceptor2] 11/6/2009 08:38

Excellent trading statement released today, which was recieved well by the market giving a 3p rise to 51.5p. One large trade at 08:14 for 500,000 @ 51.5p, not showing if it's a buy or sell but judging by share price reaction it looks like a buy.

[interceptor2] 22/5/2009 12:25

1.8m transaction this morning at 49.5p, can't tell either sell or buy on my platform.

[interceptor2] 18/5/2009 23:42

I agree it's very encouraging that they say not moving forecasts yet, which says to me that they intend to upgrade at a future date. I think the EPS forecast of 3.37p is very conservative when you look at last interims of 1.69p.

[interceptor2] 18/5/2009 11:55

All buying today with last 27k purchase at 50p, does anyone know if sys have been mentioned over the weekend.

[interceptor2] 14/5/2009 12:49

Daniel Stewart gave a reiteration of buy rating today with 58p price target.

[interceptor2] 14/5/2009 11:40

I can't work out how to paste the charts here either, shame because it is showing a lovely breakout.

[5dally] 14/5/2009 10:47

Not me I have failed twice recently on my attempts,,,don't know what I am doing wrong as I have been sussesfull in the past :-(

Glad I got in a couple of weeks ago :-)

[gerdmuller] 14/5/2009 09:13

Price is starting to move well. It sometimes takes an initial rise before people start to realise a lot of these small cos are worth buying at these levels.

Does anyone have the ability to add a chart to this?

[interceptor2] 14/5/2009 07:39

see below.......

Contract win for clinical intelligence systems (System C Healthcare)


TIDMSYS

RNS Number : 2321S
System C Healthcare plc
14 May 2009

?
System C Healthcare
System C Healthcare wins contract for clinical intelligence systems
NHS Connecting for Health has awarded a contract to System C to design, develop
and implement pilot Clinical Intelligence Systems in over a dozen NHS Trusts
across all ten English Strategic Health Authorities. The systems will provide
clinicians with tools that will help them focus on clinical quality, and present
them with the relevant and timely information they need to inform daily
decisions that improve quality of patient care.
System C will also supply training and knowledge transfer to provide the user
organisations with in-house development capability to change and enhance the new
clinical intelligence systems including the ability to extend the tools to
support other clinical specialties, services and practices.
ENDS

[interceptor2] 13/5/2009 09:21

Hopefully we will see soon who were behind the large transactions yesteday, would be nice if Directors were buying, but with a trading statement due soon, it would be unlikely.

[5dally] 13/5/2009 08:47

Small buy this morning,,,a few more and this will move IMO

[5dally] 12/5/2009 18:30

Noticed those trades, would love to know if they are buy's or sell's

[interceptor2] 12/5/2009 16:17

16:04 2 x near 2 million transactions @ 43p wonder whos behind this, could be a rns soon. I believe these to be purchases because the share price has firmed up another 1p, but my platform isn't showing a buy or sell.

Looking at the chart sys is closing in on resistance at 45p.

[5dally] 12/5/2009 16:05

Very interesting indeed :-) thank you Hoodless

[interceptor2] 12/5/2009 14:44

A 400.000 buy order has just gone through @ 43p at 14:37, which is a big deal for this share. Becoming interesting..............

[interceptor2] 12/5/2009 14:37

Pleased to see SYS burst into life up to 42p now. Good volume today with 77k buys to 36k sells so far, look forward to a trading statement soon.

[5dally] 12/5/2009 13:23

Yes these do look promising GerfMuller ;-)

Four Broker BUY'S

This from HOODLESS

Monday 5 May 2009

Analyst: Julian Tolley, Research Director, Hoodless Brennan


System C Healthcare (SYS, 38p, £34.1m) Has announced the acquisition of Bluestar UK Ltd for a maximum consideration of £3m cash, £0.4m on completion with the remainder payable over 3 years assuming the company achieves a cumulative £2.12m profits. Bluestar provides innovative information systems that include RFID tagging of patients and data collection systems. It has been appointed by 25 NHS Trusts. In the year ending October 2008 Bluestar achieved revenues of £2.7m, pre-tax profits of £0.2m and had an NAV of £0.2m. Overall the acquisition should be EPS enhancing. Ahead of this announcement forecasts to May 2009 were for pre-tax profits of £4.2m with 3.5p EPS and for £4.6m with 3.8p EPS to May 2010. Solid value, BUY up to 49p level.

[gerdmuller] 12/5/2009 13:09

Bought a few this am on a december spread bet. Don't know a lot about these yet but they look promising at this level.

[5dally] 12/5/2009 12:49

and up again :-)some missing the boat here I think

[5dally] 12/5/2009 09:34

Now we are moving ;-)

[5dally] 12/5/2009 08:28

On the move this morning,,,,spread a bit wide but some volume should see that narrow all IMO

[interceptor2] 08/5/2009 10:47

All it would take to see a fast move north, could be a postive trading statement with the words exceeding in the text, or a contract win or two. Then we would see a change of sentiment.

"Exceeding" has to be my favourite word in the English language.